An overview of tropomyosin as an important seafood allergen: Structure, cross‐reactivity, epitopes, allergenicity, and processing modifications

JH Cheng, H Wang, DW Sun - … in Food Science and Food Safety, 2022 - Wiley Online Library
Tropomyosin (TM) is a major allergen in crustaceans, which often causes allergy and is fatal
to some consumers. Currently, the most effective treatment is to avoid ingesting TM …

Allergen immunotherapy: current and future trends

GF Pavón-Romero, MI Parra-Vargas… - Cells, 2022 - mdpi.com
Allergen immunotherapy (AIT) is the sole disease-modifying treatment for allergic rhinitis; it
prevents rhinitis from progressing to asthma and lowers medication use. AIT against mites …

Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning

EK Makowski, T Wang, JM Zupancic, J Huang… - Nature Biomedical …, 2024 - nature.com
Antibody development, delivery, and efficacy are influenced by antibody-antigen affinity
interactions, off-target interactions that reduce antibody bioavailability and …

Design of a multi-epitope vaccine candidate against Brucella melitensis

M Li, Y Zhu, C Niu, X Xie, G Haimiti, W Guo, M Yu… - Scientific Reports, 2022 - nature.com
Brucella is a typical facultative intracellular bacterium that can cause zoonotic infections. For
Brucella, it is difficult to eliminate with current medical treatment. Therefore, a multi-epitope …

Principles and practical applications of structure-based vaccine design

PO Byrne, JS McLellan - Current opinion in immunology, 2022 - Elsevier
Highlights•Summary of the basic principles of structure-based vaccine design.•Review of
recent advances (the years 2019–2021) in structure-based vaccine design.•Preview of …

Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB

P Cheng, F Jiang, G Wang, J Wang, Y Xue… - Frontiers in …, 2023 - frontiersin.org
Background With the increasing incidence of tuberculosis (TB) and the shortcomings of
existing TB vaccines to prevent TB in adults, new TB vaccines need to be developed to …

PP19128R, a Multiepitope Vaccine Designed to Prevent Latent Tuberculosis Infection, Induced Immune Responses In Silico and In Vitro Assays

F Jiang, C Peng, P Cheng, J Wang, J Lian, W Gong - Vaccines, 2023 - mdpi.com
Background: Latent tuberculosis infection (LTBI) is the primary source of active tuberculosis
(ATB), but a preventive vaccine against LTBI is lacking. Methods: In this study, dominant …

Immunoinformatic analysis of T-and B-cell epitopes for SARS-CoV-2 vaccine design

D Wang, J Mai, W Zhou, W Yu, Y Zhan, N Wang… - Vaccines, 2020 - mdpi.com
Currently, there is limited knowledge about the immunological profiles of Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). We used computer-based …

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

G Richard, MF Princiotta, D Bridon… - Expert Review of …, 2022 - Taylor & Francis
Introduction The field of cancer therapy has undergone a major transformation in less than a
decade due to the introduction of checkpoint inhibitors, the advent of next generation …

A comprehensive approach to developing a multi-epitope vaccine against Mycobacterium tuberculosis: from in silico design to in vitro immunization evaluation

F Jiang, Y Han, Y Liu, Y Xue, P Cheng, L Xiao… - Frontiers in …, 2023 - frontiersin.org
Introduction The Bacillus Calmette-Guérin (BCG) vaccine, currently used against
tuberculosis (TB), exhibits inconsistent efficacy, highlighting the need for more potent TB …